TOCOX—a randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk - Groom, K M; Shennan, A H; Jones, B A; Seed, P; Bennett, P R (BJOG, 2005)